Concussion symptoms aren’t always immediate, but study results have shown a particular biomarker can be found in a patient’s blood for as long as a week.
Invitae announces new panels for pediatric, rare diseases, neuromuscular, and inherited metabolic conditions, taking its coverage well beyond oncology to more than 1000 genes.
In addition to recommendations, guidance, and emergency use authorizations, FDA wants to do more to support development of Zika diagnostic tests.
A study of over 10,000 patients tested with a multigene hereditary cancer panel finds that the approach commonly spots hereditary cancer-linked gene variants that single gene tests might miss.
In recent months, genetic testing company Invitae has dramatically expanded its test menu, focusing on diagnosing disease using a broad platform.
Noted biotech investor G. Steven Burrill had been accused of embezzling $17 million. Now, a venture firm launched by Burrill is charging PwC with being complicit in the scheme. Qmed Staff G. Steven Burrill A venture firm created by Burrill & Co. is suing PwC as well as G...
The development of biologic-delivery devices requires input from the materials science, biology, chemistry, toxicology, biomedical, mechanical engineering, and other disciplines
Cells are complex structures, making them difficult to replicate in the lab. But a team of Israeli scientists have taken a step in that direction by engineering a silicon chip that can produce proteins from DNA, the most basic function of life. The system, which was designed to be relatively simple...
For some people being well isn't enough. They want to be better. That's where these biohacking devices come in.
11 Devices For Hacking Your Health — 6. NeurOptimal
11 Devices For Hacking Your Health — 7. OxyHealth Portable Hyperbaric Chambers
Scientists at the University of Edinburgh have successfully grown a fully functioning organ from transplanted laboratory-created cells in a living animal. While researchers have grown organs in controlled lab environments, this marks the first time that an organ has been created within a living...
Y-Combinator is Betting on These 7 Medtech Startups in 2014 - Ginkgo Bioworks
Y-Combinator is Betting on These 7 Medtech Startups in 2014 - Bikanta
Blood-platelet shortages may become a thing of the past, according to scientists at Brigham and Women's Hospital in Boston. The researchers have designed an industrial-strength bone marrow bioreactor that can generate human platelets in vitro, according to a hospital press release . Their study...